Theranexus (EPA:ALTHX)

PRESS RELEASE

published on 04/29/2025 at 19:00, 1 year 6 months ago

THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
Theranexus publishes financial results for 2024 & cash position as of March 31, 2025, presents progress report & plans for Batten-1 drug candidate. Board approves accounts. Continues strategic partnerships & developments

Financial Results Strategic Partnerships Clinical Trials Theranexus Batten-1
BRIEF

published on 03/06/2025 at 18:05, 1 year 7 months ago

Modification of the Theranexus liquidity contract

Liquidity Contract AMF PORTZAMPARC Theranexus Rare Neurological Diseases
BRIEF

published on 01/31/2025 at 18:10, 1 year 9 months ago

Half-yearly report on Theranexus' liquidity contract with Portzamparc

Liquidity Contract Transactions PORTZAMPARC Half-yearly Report Theranexus
BRIEF

published on 01/30/2025 at 18:05, 1 year 9 months ago

Theranexus Strengthens its Treasury and Develops its Partnerships

Treasury Theranexus Neurological Diseases Exeltis Partnership Bpifrance Financing
PRESS RELEASE

published on 01/30/2025 at 18:00, 1 year 9 months ago

THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2024 AND PRESENTS ITS PROGRESS REPORT
Theranexus announces cash position of €4.0 M as of 29 January 2025, strengthening financial outlook. Biopharmaceutical company progressing on rare neurological disease treatments, including Niemann-Pick and Gaucher diseases

Cash Position Biopharmaceutical Financial Outlook Theranexus Neurological Diseases
BRIEF

published on 01/23/2025 at 18:20, 1 year 9 months ago

Theranexus Unveils 2025 Financial Calendar

Financial Calendar Biopharmaceutical Theranexus Neurological Diseases 2025 Schedule
PRESS RELEASE

published on 01/23/2025 at 18:15, 1 year 9 months ago

THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025
Theranexus, a biopharmaceutical company in rare neurological disease treatment, announces its 2025 financial communication agenda for Euronext market. Dates subject to change

Euronext Biopharmaceutical Financial Communication Theranexus Neurological Diseases
BRIEF

published on 01/23/2025 at 18:05, 1 year 9 months ago

Theranexus Announces its Financial Agenda for 2025

Euronext Paris Financial Agenda Theranexus Financial Publications Neurological Diseases
BRIEF

published on 01/16/2025 at 18:05, 1 year 9 months ago

Theranexus: Monthly update of voting rights and shares

Voting Rights Actions Stock Market Biopharmaceutical Theranexus
BRIEF

published on 01/09/2025 at 18:05, 1 year 9 months ago

Theranexus Publishes its Letter to Shareholders

Financial Outlook Theranexus Rare Neurological Diseases Letter To Shareholders Innovative Platform

Published on 10/30/2026 at 23:35, 2 days 9 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 9 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 2 days 12 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 2 days 14 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 17 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/02/2026 at 08:57, 8 minutes ago

Original-Research: Rainbow Tours S.A. (von East Value Research GmbH ): BUY
Published on 11/02/2026 at 08:49, 16 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 11/02/2026 at 08:45, 19 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 11/02/2026 at 08:42, 22 minutes ago

Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 11/02/2026 at 08:30, 35 minutes ago

Suspension: Wildcat Gold Plc

View all EQS

Published on 10/30/2026 at 23:00, 2 days 10 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 12 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 15 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 21 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 3 days ago

Share buyback

View all LES ECHOS COMFI WIRE

News